Tag Archives: IP

Need for Patent Reform May be Overblown

admin-ajax

Amid the cacophony of calls for patent reform legislation, mounting evidence demonstrates patent trolling may be on the wane. As we reported earlier this month, the number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. A new data analysis by Unified Patents data shows more signs that patent troll suits are in decline.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

The Washington Post: Are Patents the Problem?

Tamar-Haspel

Tamar Haspel, food columnist for the Washington Post, looks at the issue of seed patents in her October column: If you’re at the right party — a party populated by agriculture wonks — the issue of patenting living organisms might get more of a rise than either religion or politics, demonstrating both that patenting is a hot issue and that agriculture wonks aren’t much of a hit at parties (trust me on this one). A Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

shutterstock_27160801

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology Hearing – Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients Witnesses Dr. Harold Varmus, Director, National Cancer Institute (NCI) at the National Institutes of Health (NIH) *(Really liked your DNA tie!) Dr. Marc Tessier-Lavigne, President and Carson Family Professor, Laboratory of Brain Development and Repair, The Rockefeller University Dr. Jay Keasling, Hubbard Howe Jr. Distinguished Professor of Biochemical Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , ,

What International Trade Agreements Have to Do with Innovation

Attendees

Innovation is not just the life-blood of the biotech industry, it is the very premise of the BIO International Convention. So what is a panel on international trade doing here? Answering this question is the task panel moderator, Richard Bergstrom, Director General, EFPIA gave to participants in the session TTIP: Can US and the EU Lead the Way in Setting New Global Benchmarks for IP, Regulatory and Market Access Issues; and each provided a piece Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Supreme Court Enunciates New Indefiniteness Standard

Noonan

The Supreme Court has once again reversed a decision by the Federal Circuit, in this case involving the proper standard for finding claims indefinite. The case, Nautilus, Inc. v. Biosig Instruments, Inc., overturned the Federal Circuit’s “insolubly ambiguous” test and substituted its own “reasonable certainty” test.  The Court left intentionally unclear the precise ways in which their new test will differ from the Federal Circuit’s abrogated test, leaving it to the lower court to decide Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,